Jason Karlawish, NEJM, Biomarker Patent Wars

Jason Karlawish, NEJM, Biomarker Patent Wars

Ownership and Exploitation Rights for Biomarkers as Tools of Medicine

LDI Senior Fellow Jason Karlawish is the co-author of a New England Journal of Medicine article arguing for a less private enterprise and more public approach to the ownership and exploitation of biomarkers as tools of medicine.  Karlawish, MD, is a professor of Medicine, Medical Ethics and Health Policy at Penn's Perelman School of Medicine.